Foldrx Pharmaceuticals
Pharmaceutical Manufacturing • 
United States • 1-10 Employees
Company overview
| Headquarters | United States |
| Phone number | +16172525500 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Employees | 1-10 |
| Socials |
Key Contact at Foldrx Pharmaceuticals
Todd Grinnell
Director, Medical Liaison Group
About Foldrx Pharmaceuticals
FoldRx Pharmaceuticals is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The folding and maintenance of proteins in a correctly folded active form is essential to normal cellular function.Accumulation of misfolded proteins, due to mutations or to defects in cellular quality control mechanisms, can prevent them from performing their normal function or result in toxic intermediates.
Foldrx Pharmaceuticals revenue & valuation
| Annual revenue | $25,300,000 |
| Revenue per employee | $12,626,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $80,900,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Foldrx Pharmaceuticals has never raised funding before.
Foldrx Pharmaceuticals Tech Stack
Discover the technologies and tools that power Foldrx Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
Austria
Ireland
Switzerland
United Kingdom
Germany
CanadaFrequently asked questions
4.8
40,000 users
